Growth Metrics

Rxo (RXO) Interest & Investment Income (2022 - 2025)

Rxo (RXO) has disclosed Interest & Investment Income for 4 consecutive years, with -$9.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income fell 12.5% year-over-year to -$9.0 million, compared with a TTM value of -$35.0 million through Dec 2025, down 16.67%, and an annual FY2025 reading of -$35.0 million, down 16.67% over the prior year.
  • Interest & Investment Income was -$9.0 million for Q4 2025 at Rxo, roughly flat from -$9.0 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1.0 million in Q3 2022 and bottomed at -$9.0 million in Q1 2025.
  • Average Interest & Investment Income over 4 years is -$7.2 million, with a median of -$8.0 million recorded in 2023.
  • The sharpest move saw Interest & Investment Income plummeted 900.0% in 2023, then grew 25.0% in 2024.
  • Year by year, Interest & Investment Income stood at -$5.0 million in 2022, then plummeted by 60.0% to -$8.0 million in 2023, then changed by 0.0% to -$8.0 million in 2024, then fell by 12.5% to -$9.0 million in 2025.
  • Business Quant data shows Interest & Investment Income for RXO at -$9.0 million in Q4 2025, -$9.0 million in Q3 2025, and -$8.0 million in Q2 2025.